Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» biotech
biotech
Biotech Financing, IPO Tide May Be Turning – Signs of a Potential Recovery?
Biotech Financing, IPO Tide May Be Turning – Signs of a Potential Recovery?
BioSpace
biotech
IPOs
Neumora Therapeutics
Rome Therapeutics
Generate Biomedicines
Flag link:
The 10 highest value R&D projects in biopharma
The 10 highest value R&D projects in biopharma
Fierce Biotech
R&D
biotech
Merck
sotatercept
Daiichi Sankyo
AstraZeneca
Dato-DXd
Novo Nordisk
CagriSema
Eli Lilly
donanemab
Karuna Therapeutics
Zai Lab
KarXT
Moderna Therapeutics
mRNA-1647
Novartis
iptacopan
Madrigal Pharmaceuticals
resmetirom
Cytokinetics
aficamten
Roche
Chugai
tiragolumab
Flag link:
‘It’s Like Ross Was Planning This Project.’ Perot Sr.’s HQ Finds New Life as Biotech Development
‘It’s Like Ross Was Planning This Project.’ Perot Sr.’s HQ Finds New Life as Biotech Development
D Magazine
biotech
Texas
NexPoint
Flag link:
Vivek Ramaswamy’s brashness made waves in the Republican debate. He did the same in biotech
Vivek Ramaswamy’s brashness made waves in the Republican debate. He did the same in biotech
Stat
Vivek Ramaswamy
2024 Presidential election
biotech
Roivant
Flag link:
Mass Layoffs Continue Across The Biotech Sector. What Does This Mean For Pharma’s Future?
Mass Layoffs Continue Across The Biotech Sector. What Does This Mean For Pharma’s Future?
Forbes
biotech
layoffs
Flag link:
Are biotech VCs headed for better times? In one firm’s success, lessons for turning crisis into profit
Are biotech VCs headed for better times? In one firm’s success, lessons for turning crisis into profit
Stat
biotech
funding
venture capital
The Column Group
Flag link:
Are biotech VCs headed for better times? In one firm’s success, lessons for turning crisis into profit
Are biotech VCs headed for better times? In one firm’s success, lessons for turning crisis into profit
Stat
biotech
funding
venture capital
Flag link:
Biopharma sector still growing despite layoff wave, Stifel report finds
Biopharma sector still growing despite layoff wave, Stifel report finds
BioPharma Dive
biopharma
biotech
jobs
layoffs
Flag link:
Early-stage biotech funding on pace to drop 40% in 2023, HSBC report shows
Early-stage biotech funding on pace to drop 40% in 2023, HSBC report shows
BioPharma Dive
biotech
funding
HSBC
Flag link:
Biophama's flotation haul creeps higher
Biophama's flotation haul creeps higher
EP Vantage
IPOs
biotech
Acelyrin
Apogee Therapeutics
Azitra
CytoMed Therapeutics
Intensity Therapeutics
Mineralys Therapeutics
Paragon Therapeutics
Sagimet Biosciences
Structure Therapeutics
Turnstone Biologics
Flag link:
Women left out of VC club fight for their identity, pulling each other up one by one
Women left out of VC club fight for their identity, pulling each other up one by one
Fierce Biotech
venture capital
biotech
funding
Norwest Venture Partners
women
Flag link:
Biotech IPOs in 2023: Shaping the Future of Innovation
Biotech IPOs in 2023: Shaping the Future of Innovation
Xtalks
biotech
IPOs
Flag link:
Serial biotech founder Tim Springer on investing in startups and democratizing antibody research
Serial biotech founder Tim Springer on investing in startups and democratizing antibody research
BioPharma Dive
Tim Springer
Harvard
biotech
R&D
Flag link:
3 Key Biotech Trends for 2023 And Beyond
3 Key Biotech Trends for 2023 And Beyond
Motley Fool
biotech
collaboration
artificial intelligence
clinical trials
drug development
Flag link:
So you think you can go public? Few biotechs dance with Wall Street
So you think you can go public? Few biotechs dance with Wall Street
Fierce Biotech
biotech
IPOs
Structure Therapeutics
Mineralys Therapeutics
Coya Therapeutics
Flag link:
After a record run, fewer biotechs are going public. Here’s how they’re performing.
After a record run, fewer biotechs are going public. Here’s how they’re performing.
BioPharma Dive
biotech
IPOs
Flag link:
Biotechs see 'staggering' 87% rise in layoffs during Q1, on pace to overtake 2022
Biotechs see 'staggering' 87% rise in layoffs during Q1, on pace to overtake 2022
Fierce Biotech
layoffs
biotech
Flag link:
Biotech layoffs gather pace as industry downturn persists
Biotech layoffs gather pace as industry downturn persists
BioPharma Dive
layoffs
biotech
Amgen
Pfizer
Roche
Jounce Therapeutics
Fate Therapeutics
Molecular Templates
Sorrento Therapeutics
Flag link:
Biopharma Rallies Behind FDA After Texas Abortion Pill Ruling
Biopharma Rallies Behind FDA After Texas Abortion Pill Ruling
BioSpace
biotech
FDA
Texas
legal
mifepristone
abortion pill
Flag link:
Biotech leaders 'cannot stay quiet' as judge blocks abortion pill approval
Biotech leaders 'cannot stay quiet' as judge blocks abortion pill approval
Fierce Biotech
biotech
FDA
legal
abortion pill
mifepristone
Flag link:
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »